Summary
IDEXX Laboratories, Inc. (IDXX) filed a Form 8-K on April 23, 2013, to report its financial results for the first quarter ended March 31, 2013. The filing primarily furnished a press release announcing these results. While the specific financial figures are not detailed within the 8-K itself, it serves as the official channel for disseminating this key information to investors and the market. Investors should refer to the furnished press release (Exhibit 99.1) for detailed financial performance, including revenue, earnings, and any forward-looking guidance provided by the company for the upcoming periods. This announcement is crucial for understanding the company's recent operational performance and its outlook in the animal health and diagnostics sector.
Key Highlights
- 1IDEXX Laboratories announced its first quarter financial results for the period ending March 31, 2013.
- 2The company filed a Form 8-K to report these results, as required by SEC regulations.
- 3The detailed financial results and commentary are provided in a press release furnished as Exhibit 99.1 to the 8-K.
- 4The information is furnished under Item 2.02 (Results of Operations and Financial Condition).
- 5The filing states that the information is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings.
- 6The Chief Financial Officer, Merilee Raines, signed the report, indicating official company authorization.